Ohio Public Employees Retirement System (OPERS)’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-81,106
Closed -$281K 2324
2025
Q3
$281K Buy
81,106
+12,200
+18% +$45.8K ﹤0.01% 1612
2025
Q2
$234K Buy
68,906
+56,333
+448% +$188K ﹤0.01% 1625
2025
Q1
$50.4K Buy
+12,573
New +$65.2K ﹤0.01% 1901
2024
Q4
Sell
-48,520
Closed -$269K 2371
2024
Q3
$269K Buy
+48,520
New +$275K ﹤0.01% 1501

Other funds holding CTKB

Ohio Public Employees Retirement System (OPERS)'s CTKB Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Cytek Biosciences (CTKB) in Q4 2025, closing a stake of 81,106 shares — an estimated $281K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CTKB in Q3 2024 and held it in 4 quarters. The position peaked at $281K in Q3 2025. 155 funds tracked by Wall St. Rank hold CTKB as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Cytek Biosciences position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 81,106 Cytek Biosciences shares in Q4 2025, an estimated $281K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Cytek Biosciences in Q3 2024 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Cytek Biosciences position peaked at $281K in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.